• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002).

作者信息

Bugat R, Bataillard A, Lesimple T, Voigt J J, Culine S, Lortholary A, Merrouche Y, Ganem G, Kaminsky M C, Negrier S, Perol M, Laforêt C, Bedossa P, Bertrand G, Coindre J M, Fizazi K

机构信息

Institut Claudius Regaud, Toulouse, France.

出版信息

Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S59-66. doi: 10.1038/sj.bjc.6601085.

DOI:10.1038/sj.bjc.6601085
PMID:12915904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2753014/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/3def5be61d7f/89-6601085f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/bedf492bc5fe/89-6601085f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/683ff37bfcfa/89-6601085f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/baaa204e50d1/89-6601085f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/751a376867fd/89-6601085f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/e30a79b5b24a/89-6601085f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/4fe5e8906190/89-6601085f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/33d10297906d/89-6601085f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/98a24fad0b42/89-6601085f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/282e3847fcfd/89-6601085f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/3def5be61d7f/89-6601085f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/bedf492bc5fe/89-6601085f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/683ff37bfcfa/89-6601085f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/baaa204e50d1/89-6601085f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/751a376867fd/89-6601085f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/e30a79b5b24a/89-6601085f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/4fe5e8906190/89-6601085f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/33d10297906d/89-6601085f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/98a24fad0b42/89-6601085f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/282e3847fcfd/89-6601085f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0364/2753014/3def5be61d7f/89-6601085f10.jpg

相似文献

1
Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002).不明原发部位癌患者管理的标准、选择及建议总结（2002年）
Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S59-66. doi: 10.1038/sj.bjc.6601085.
2
[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].[不明原发部位癌患者管理的标准、选项与建议]
Bull Cancer. 2002 Oct;89(10):869-75.
3
[Diagnosis and therapy of occult primary tumor with lymph node metastases in the area of the head and neck].[头颈部区域伴有淋巴结转移的隐匿性原发性肿瘤的诊断与治疗]
HNO. 1997 Jul;45(7):573-83.
4
[What is the standard treatment approach for a cervical lymph node metastasis from a squamous cell carcinoma of unknown origin?].[来源不明的鳞状细胞癌所致颈部淋巴结转移的标准治疗方法是什么？]
Rev Med Liege. 2014;69 Suppl 1:58-62.
5
Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.原发灶不明的鳞状细胞癌颈部淋巴结转移
Cancer Treat Rev. 2004 Apr;30(2):153-64. doi: 10.1016/j.ctrv.2003.10.001.
6
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001).非转移性前列腺癌患者管理的标准、选项及建议总结（2001年）
Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S50-8. doi: 10.1038/sj.bjc.6601084.
7
[Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].[1979年至1998年转诊至荷兰癌症研究所/安托尼·范·列文虎克医院的39例原发灶不明的鳞状细胞癌颈部淋巴结转移患者的诊断与治疗]
Ned Tijdschr Geneeskd. 2000 Jul 8;144(28):1355-60.
8
Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.不明原发肿瘤颈部淋巴结转移的回顾性研究及文献综述
Strahlenther Onkol. 2005 Jun;181(6):355-62. doi: 10.1007/s00066-005-1338-2.
9
Management of unknown primary tumor.未知原发肿瘤的管理
Head Neck. 2003 Jun;25(6):499-504. doi: 10.1002/hed.10287.
10
[Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: a retrospective analysis of treatment strategies and prognosis].[原发灶不明的颈部淋巴结鳞状细胞癌：治疗策略与预后的回顾性分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Jan;48(1):32-6.

引用本文的文献

1
Cancer of Unknown Primary: A Case Report on the Recognition of Its Clinical Entity and Standard of Care Management.原发灶不明癌：关于其临床实体识别及标准治疗管理的病例报告
Cureus. 2025 Jun 20;17(6):e86451. doi: 10.7759/cureus.86451. eCollection 2025 Jun.
2
Revisiting the use of CK7 and CK20 immunohistochemical stains in pathological diagnoses.重新审视细胞角蛋白7和细胞角蛋白20免疫组化染色在病理诊断中的应用。
Diagn Pathol. 2025 Apr 11;20(1):40. doi: 10.1186/s13000-025-01638-x.
3
A case of pelvic squamous cell carcinoma of unknown primary origin that responded well to radiotherapy and nivolumab.

本文引用的文献

1
[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].[不明原发部位癌患者管理的标准、选项与建议]
Bull Cancer. 2002 Oct;89(10):869-75.
2
SOR: project methodology.SOR：项目方法学。
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):8-16. doi: 10.1054/bjoc.2000.1757.
一例原发灶不明的盆腔鳞状细胞癌，对放疗和纳武单抗反应良好。
Radiol Case Rep. 2024 Feb 23;19(5):1881-1885. doi: 10.1016/j.radcr.2024.01.062. eCollection 2024 May.
4
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.肿瘤标志物在识别不明原发癌患者中有利或不利亚组的诊断价值：一项回顾性研究。
BMC Cancer. 2022 Apr 14;22(1):412. doi: 10.1186/s12885-022-09514-3.
5
The Diminishing Importance of Primary Site Identification in Cancer of Unknown Primary: A Canadian Single-Center Experience.原发灶不明癌症中原发部位识别重要性的降低：一项加拿大单中心经验
Front Oncol. 2021 Mar 3;11:634563. doi: 10.3389/fonc.2021.634563. eCollection 2021.
6
Signet-ring cell adenocarcinoma of unknown primary presenting with superior vena cava (SVC) syndrome: rare type of cancer.以腔静脉综合征为表现的原发灶不明的印戒细胞腺癌：罕见的癌症类型。
BMJ Case Rep. 2019 Dec 29;12(12):e232269. doi: 10.1136/bcr-2019-232269.
7
Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.PET/CT 对不明原发灶癌患者临床管理的影响——一项 PET/CT 登记研究。
Eur Radiol. 2020 Mar;30(3):1325-1333. doi: 10.1007/s00330-019-06518-9. Epub 2019 Nov 14.
8
How I treat cancers of unknown primary.我如何治疗原发灶不明的癌症。
ESMO Open. 2019 May 10;4(Suppl 2):e000502. doi: 10.1136/esmoopen-2019-000502. eCollection 2019.
9
SEOM clinical guideline on unknown primary cancer (2017).SEOM 临床指南：不明原发灶肿瘤（2017）
Clin Transl Oncol. 2018 Jan;20(1):89-96. doi: 10.1007/s12094-017-1807-y. Epub 2017 Dec 11.
10
Prognostic clinicopathologic factors in carcinoma of unknown primary origin: a study of 106 consecutive cases.不明原发灶癌的预后临床病理因素：106例连续病例研究
Oncotarget. 2017 Mar 8;8(37):62630-62640. doi: 10.18632/oncotarget.16021. eCollection 2017 Sep 22.